Cite
Linas BP, Morgan JR, Pho MT, et al. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2016;4(1):ofw266doi: 10.1093/ofid/ofw266.
Linas, B. P., Morgan, J. R., Pho, M. T., Leff, J. A., Schackman, B. R., Horsburgh, C. R., Assoumou, S. A., Salomon, J. A., Weinstein, M. C., Freedberg, K. A., & Kim, A. Y. (2017). Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open forum infectious diseases, 4(1), ofw266. https://doi.org/10.1093/ofid/ofw266
Linas, Benjamin P, et al. "Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1." Open forum infectious diseases vol. 4,1 (2017): ofw266. doi: https://doi.org/10.1093/ofid/ofw266
Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2016 Dec 27;4(1):ofw266. doi: 10.1093/ofid/ofw266. eCollection 2017. PMID: 28480259; PMCID: PMC5414108.
Copy
Download .nbib